Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

02.11.23	Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting (Businesswire)
02.11.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
31.10.23	Pfizer Reaffirms FY23 Outlook - Update (RTTNews)
31.10.23	Pfizer Inc. Q3 Earnings Summary (RTTNews)
31.10.23	Pfizer Reports Third-Quarter 2023 Results (Businesswire)
26.10.23	Pfizer Reports Positive Data For MRNA-based Combination Vaccine Program Against Influenza & COVID-19 (RTTNews)
26.10.23	Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 (Businesswire)
25.10.23	Pfizer To Expand Access To Cadence Products And Programming Toolkits For Advanced Molecular Design (RTTNews)
20.10.23	Pfizer Secures FDA Approval For Penbraya (RTTNews)
20.10.23	FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents (Businesswire)
16.10.23	Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis (PR Newswire)
16.10.23	Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023 (PR Newswire)
13.10.23	Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance (Businesswire)
13.10.23	Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis (RTTNews)
12.10.23	Pfizer: FDA Approves BRAFTOVI + MEKTOVI In Treatment Of Metastatic NSCLC With BRAF V600E Mutation (RTTNews)
12.10.23	U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer (Businesswire)
05.10.23	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases (Businesswire)
04.10.23	Pfizer Declares Fourth-Quarter 2023 Dividend (Businesswire)
03.10.23	Pfizer's Hospira Recalls Sodium Bicarbonate, Lidocaine HCl Injections (RTTNews)
27.09.23	Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer (PR Newswire)
26.09.23	Pfizer Plant In North Carolina Restarts Production After Tornado Damage (RTTNews)
23.09.23	CDC Recommends Pfizer's Vaccine 'Abrysvo' To Help Protect Babies Against Severe RSV Illness (RTTNews)
22.09.23	Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV (Businesswire)
19.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
19.09.23	Pfizer's LITFULO To Treat Severe Alopecia Areata Gets Approval In EU (RTTNews)
19.09.23	GSK : EC Authorizes ViiV Healthcare's Apretude For HIV Prevention (RTTNews)
19.09.23	European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata (Businesswire)
18.09.23	Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts (Businesswire)
13.09.23	CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine (RTTNews)
13.09.23	European Medicines Agency Validates Type II Variation for Astellas' XTANDI® (enzalutamide) for Treatment of Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (PR Newswire)
12.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
12.09.23	FDA Approves Pfizer-BioNTech's Updated COVID-19 Vaccine (RTTNews)
11.09.23	Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine (Businesswire)
05.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
30.08.23	Pfizer, BioNTech Obtain Positive CHMP Opinion For Omicron XBB.1.5-adapted COVID-19 Vaccine In EU (RTTNews)
30.08.23	Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences (Businesswire)
30.08.23	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union (Businesswire)
25.08.23	EU Approves Pfizer' Abrysvo To Help Protect Infants And Older Adults From RSV (RTTNews)
24.08.23	European Commission Approves Pfizer’s ABRYSVO™ to Help Protect Infants through Maternal Immunization and Older Adults from RSV (Businesswire)
24.08.23	Everest Medicines Announces Interim Results for First Half of 2023 (PR Newswire)
23.08.23	Pfizer, Astellas' XTANDI Gets Priority Review In Non-metastatic Castration-sensitive Prostate Cancer (RTTNews)
23.08.23	FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (PR Newswire)
22.08.23	FDA Approves Pfizer's Abrysvo For Pregnant Individuals To Prevent RSV In Infants (RTTNews)
21.08.23	U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age (Businesswire)
14.08.23	Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma (Businesswire)
04.08.23	Pfizer Faces Distribution Restrictions Following Tornado Damage To North Carolina Plant (RTTNews)
01.08.23	Pfizer Reaffirms FY23 Adj. EPS Outlook - Update (RTTNews)
01.08.23	Pfizer Inc. Q2 Profit Decreases, but beats estimates (RTTNews)
01.08.23	Pfizer Reports Second-Quarter 2023 Results (Businesswire)
31.07.23	Biotech Stocks Facing FDA Decision In August 2023 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

17:57		Börse Europa in Grün: STOXX 50 steigt schlussendlich
17:57		Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50
17:57		Dienstagshandel in London: Letztendlich Gewinne im FTSE 100
16:15		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
16:02		Dow Jones 30 Industrial-Papier Merck-Aktie: So viel Verlust hätte ein Merck-Investment von vor einem Jahr eingefahren
16:02		S&P 500-Titel Pfizer-Aktie: So viel Verlust hätte ein Investment in Pfizer von vor einem Jahr eingebracht
16:00		NYSE-Handel: Dow Jones beginnt Dienstagshandel mit Gewinnen

17:57

Börse Europa in Grün: STOXX 50 steigt schlussendlich

17:57

Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50

17:57

Dienstagshandel in London: Letztendlich Gewinne im FTSE 100

16:15

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

16:02

Dow Jones 30 Industrial-Papier Merck-Aktie: So viel Verlust hätte ein Merck-Investment von vor einem Jahr eingefahren

16:02

S&P 500-Titel Pfizer-Aktie: So viel Verlust hätte ein Investment in Pfizer von vor einem Jahr eingebracht